Sumalinog, Chilo V.

HRN: 27-62-02  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2026
CEFTRIAXONE 1G (VIAL)
07/01/2026
07/06/2026
IV
2g
OD
Uti
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: